1. Signaling Pathways
  2. Epigenetics
    TGF-beta/Smad
  3. PKC
  4. PKC Inhibitors

PKC Inhibitors

PKC

PKCα

PKCβ

PKCγ

PKCδ

PKCε

PKCη

PKCζ

PKCθ

PKCμ

PKCι

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PKC Inhibitors, Antagonists, Activators & Modulators
Product Name PKC PKCα PKCβ PKCγ PKCδ PKCε PKCη PKCζ PKCθ PKCμ PKCι Purity
Phorbol 12-myristate 13-acetate
PKC, EC50: 11.7 nM
                    99.80%
Staurosporine
PKC, IC50: 6 nM
                    99.98%
Go 6983  
PKCα, IC50: 7 nM
PKCβ, IC50: 7 nM
PKCγ, IC50: 6 nM
PKCδ, IC50: 10 nM
   
PKCζ, IC50: 60 nM
 
PKCμ, IC50: 20000 nM
  99.32%
Mitoxantrone
PKC, IC50: 8.5 μM
                    98.70%
Midostaurin  
cPKC-α, IC50: 22 nM
cPKC-β1, IC50: 30 nM
cPKC-β2, IC50: 31 nM
cPKC-γ, IC50: 24 nM
nPKC-δ, IC50: 33 nM
nPKC-ε, IC50: 1250 nM
nPKC-η, IC50: 160 nM
aPKC-ζ, IC50: 465000 nM
      99.91%
Fasudil Hydrochloride
PKC, IC50: 12.30 μM
                    99.96%
Bisindolylmaleimide I
Bovine brain PKC, IC50: 10 nM
PKCα, IC50: 20 nM
PKCβII, IC50: 16 nM
PKCβI, IC50: 17 nM
PKCγ, IC50: 20 nM
              98.66%
Rottlerin  
PKCα, IC50: 30 μM (baculovirus-infected Sf9 insect cells)
PKCβ, IC50: 42 μM (baculovirus-infected Sf9 insect cells)
PKCγ, IC50: 40 μM (baculovirus-infected Sf9 insect cells)
PKCδ, IC50: 3 μM (Porcine spleen)
PKCε, IC50: 100 μM (baculovirus-infected Sf9 insect cells)
PKCη, IC50: 82 μM (baculovirus-infected Sf9 insect cells)
PKCζ, IC50: 100 μM (baculovirus-infected Sf9 insect cells)
      98.39%
Sotrastaurin  
PKCα, Ki: 0.95 nM
PKCβI, Ki: 0.64 nM
 
PKCδ, Ki: 2.1 nM
PKCε, Ki: 3.2 nM
PKCη, Ki: 1.8 nM
 
PKCθ, Ki: 0.22 nM
    99.79%
Verbascoside
PKC, IC50: 25 μM
                    99.83%
Mitoxantrone dihydrochloride
PKC, IC50: 8.5 μM
                    99.55%
D-erythro-Sphingosine
PKC
                    ≥98.0%
Enzastaurin  
PKCα, IC50: 39 nM
PKCβ, IC50: 6 nM
PKCγ, IC50: 83 nM
 
PKCε, IC50: 110 nM
          99.92%
Chelerythrine chloride
PKC, IC50: 660 nM
                    99.42%
Ingenol Mebutate  
PKC-α, Ki: 0.3 nM
PKC-β, Ki: 0.105 nM
PKC-γ, Ki: 0.162 nM
PKC-δ, Ki: 0.376 nM
PKC-ε, Ki: 0.171 nM
          99.65%
Afuresertib    
PKC-βI, IC50: 430 nM
     
PKCη, IC50: 210 nM
 
PKCθ, IC50: 510 nM
    99.53%
Darovasertib  
PKCα, IC50: 1.9 nM
           
PKCθ, IC50: 0.4 nM
    99.42%
TPPB
PKC, Ki: 11.9 nM
                    99.92%
Daphnetin
PKC, IC50: 25.01 μM
                    99.86%
DCP-LA          
PKCε
          ≥98.0%
Ro 31-8220 mesylate
Rat Brain PKC, IC50: 23 nM
PKC-α, IC50: 5 nM
PKC-βI, IC50: 24 nM
PKC-βII, IC50: 14 nM
PKC-γ, IC50: 27 nM
 
PKC-ε, IC50: 24 nM
          99.57%
CGP60474
PKC
                    99.23%
BJE6-106  
PKCα, IC50: 50 μM
   
PKCδ, IC50: 0.05 μM
            99.93%
KT5823
PKC, Ki: 4 μM
                    99.90%
CMPD101  
PKCα, IC50: 8.1 μM
                  98.95%
Ruboxistaurin  
PKCα, IC50: 360 nM
PKC-βI, IC50: 4.7 nM
PKC-βII, IC50: 5.9 nM
PKCγ, IC50: 300 nM
PKCδ, IC50: 250 nM
PKCε, IC50: 600 nM
PKCη, IC50: 52 nM
        99.90%
Prostratin
PKC, Ki: 12.5 nM
                    99.80%
Valrubicin
TPA-activated PKC, IC50: 0.85 μM
PDBu-activated PKC, IC50: 1.25 μM
                    99.60%
(-)-Indolactam V  
PKCα-C1A-long, Kd: 20.8 nM
PKCα-C1B-long, Kd: 4000 nM
PKCβ-C1A-long, Kd: 18.9 nM
PKCβ-C1B, Kd: 137 nM
PKCγ-C1A, Kd: 138 nM
PKCγ-C1B, Kd: 213 nM
PKCγ-CRD2, Ki: 1030 nM
PKCδ-C1B, Kd: 8.3 nM
PKCδ-C1A, Kd: 1900 nM
PKCε-C1B, Kd: 7.7 nM
PKCε-C1A, Kd: 4110 nM
PKCη-CRD2, Ki: 3.36 nM
PKCη-C1B, Kd: 5.5 nM
PKCη-C1A, Kd: 3770 nM
 
PKCθ-C1B, Kd: 8.7 nM
    98.75%
R 59-022
PKC
                    99.82%
Ingenol
PKC, Ki: 30 μM
                    99.51%
CC-90005                
PKCθ, IC50: 8 nM
    99.67%
Epsilon-V1-2          
PKCε
         
VTX-27  
PKCα, Ki: 356 nM
   
PKCδ, Ki: 16 nM
     
PKCθ, Ki: 0.08 nM
    99.02%
PKC-theta inhibitor 2                
PKCθ, IC50: 12 nM
    99.37%
PKC-IN-1  
Human PKCα, IC50: 2.3 nM
Human PKCα, Ki: 10.4 nM
Human PKCβII, IC50: 7.6 nM
Human PKCβI, IC50: 8.1 nM
Human PKCβ, Ki: 5.3 nM
Human PKCγ, IC50: 57.5 nM
 
Human PKCε, IC50: 808 nM
   
Human PKCθ, IC50: 25.6 nM
Human PKC mu, IC50: 314 nM
  99.79%
HA-100
PKC, IC50: 12 μM
PKC, Ki: 6.5 μM
                    99.80%
PKCβ inhibitor 1  
PKCα, IC50: 331 nM
human PKCβ1, IC50: 21 nM
human PKCβ2, IC50: 5 nM
                99.40%
Delcasertib hydrochloride        
δPKC
            99.86%
CRT0066854              
PKCζ, IC50: 639 nM
      99.54%
Aurothiomalate sodium                    
PKCι
≥98.0%
Bisindolylmaleimide X hydrochloride
PKC
                    98.90%
Afuresertib hydrochloride    
PKC-βI, IC50: 430 nM
     
PKCη, IC50: 210 nM
 
PKCθ, IC50: 510 nM
    99.95%
SB-218078
PKC, IC50: 1000 nM
                    98.3%
Psychosine
PKC
                    ≥99.0%
Ruboxistaurin hydrochloride  
PKCα, IC50: 360 nM
PKCβI, IC50: 4.7 nM
PKCβII, IC50: 5.9 nM
PKCγ, IC50: 300 nM
PKCδ, IC50: 250 nM
PKCε, IC50: 600 nM
PKCη, IC50: 52 nM
        99.94%
ζ-Stat              
aPKC-ζ, IC50: 5 μM
     
TCS 21311  
PKCα, IC50: 13 nM
           
PKCθ, IC50: 68 nM
    99.18%
PKC-theta inhibitor 1  
PKCα, Ki: 1020 μM
   
PKCδ, Ki: 392 μM
     
PKCθ, Ki: 6 nM
    99.73%
PKCiota-IN-2 formic  
PKCα, IC50: 71 nM
     
PKCε, IC50: 350 nM
       
PKCι, IC50: 2.8 nM
99.23%
N-Desmethyltamoxifen hydrochloride
PKC
                    99.93%
PS432              
PKCζ, IC50: 18.5 μM
   
PKCι, IC50: 16.9 μM
≥99.0%
R 59-022 hydrochloride
PKC
                    98.88%
Bisindolylmaleimide IV
PKC, IC50: 0.1-0.55 μM
                    99.62%
Bisindolylmaleimide VIII acetate
Rat Brain PKC, IC50: 158 nM
PKC-α, IC50: 53 nM
PKC-βI, IC50: 195 nM
PKC-βII, IC50: 163 nM
PKC-γ, IC50: 213 nM
 
PKC-ε, IC50: 175 nM
          99.68%
C8-Ceramide
PKC
                    ≥98.0%
Protein kinase inhibitor H-7
PKC, Ki: 6 μM
                    99.97%
Bisindolylmaleimide I hydrochloride
Bovine brain PKC, IC50: 10 nM
PKCα, IC50: 20 nM
PKC-βII, IC50: 16 nM
PKC-βI, IC50: 17 nM
PKCγ, IC50: 20 nM
              99.18%
ML192    
PKCβII
               
Bisindolylmaleimide III  
PKCα
                  98.95%
Ruboxistaurin mesylate  
PKCα, IC50: 360 nM
PKC-βI, IC50: 4.7 nM
PKC-βII, IC50: 5.9 nM
PKCγ, IC50: 300 nM
PKCδ, IC50: 250 nM
PKCε, IC50: 600 nM
PKCη, IC50: 52 nM
        99.87%
Bisindolylmaleimide XI hydrochloride  
PKC-α, IC50: 9 nM
PKC-βI, IC50: 28 nM
PKC-βII, IC50: 31 nM
PKC-γ, IC50: 37 nM
 
PKC-ε, IC50: 108 nM
          ≥98.0%
CRT0066854 hydrochloride              
PKCζ, IC50: 639 nM
      99.29%
Sphingosine (d14:1)
PKC
                    ≥99.0%
Spisulosine              
PKCζ
      99.00%
A-3 hydrochloride
PKC, Ki: 47 μM
                    99.75%
DCPLA-ME          
PKCε
          ≥98.0%
Hu7691            
PKCη, IC50: 629 nM
       
ζ-Stat trisodium              
aPKC-ζ, IC50: 5 μM
     
SB 220025
PKC, IC50: 2.89 μM
                    99.90%
CGP-53353    
PKCβII, IC50: 0.41 mM
PKCβI, IC50: 3.8 mM
                98.87%
(S)-Ro 32-0432  
PKCα, IC50: 9.3 nM
PKC-βI, IC50: 28 nM
PKC-βII, IC50: 30 nM
PKCγ, IC50: 36.5 nM
 
PKCε, IC50: 108.3 nM
         
Delcasertib        
δPKC
            98.21%
TAS-301
PKC
                    99.61%
Chelerythrine
PKC, IC50: 0.7 μM
                   
OSU-2S        
PKCδ
           
Fasudil
PKC, IC50: 12.3 μM
                   
PKCTheta-IN-2                
PKCθ, IC50: 0.25 nM
    99.49%
Ro 31-8220
Rat Brain PKC, IC50: 23 nM
PKC-α, IC50: 5 nM
PKC-βII, IC50: 14 nM
PKC-βI, IC50: 24 nM
PKC-γ, IC50: 27 nM
 
PKC-ε, IC50: 24 nM
         
Fasudil hydrochloride semihydrate
PKC, IC50: 12.3 μM
                   
Fasudil dihydrochloride
PKC, IC50: 12.3 μM
                   
Hu7691 free base            
PKCη, IC50: 629 nM
       
Mitoxantrone diacetate
PKC, IC50: 8.5 μM
                   
PKCTheta-IN-1                
PKCθ, IC50: 0.1 nM
   
GSK-3β inhibitor 13                
PKCθ, IC50: 0.36 μM
   
HBDDE  
PKCα, IC50: 43 μM
 
PKCγ, IC50: 50 μM
              98.03%
Leucosceptoside A  
PKCα, IC50: 19 μM
                 
CIDD-0072424          
PKCε, Ki: 54 nM
         
PKCiota-IN-1  
PKCα, IC50: 45 nM
     
PKCε, IC50: 450 nM
       
PKCι, IC50: 2.7 nM
HA-100 dihydrochloride
PKC, IC50: 12 μM
PKC, Ki: 6.5 μM
                   
CDK8-IN-12                
PKCθ, Ki: 109 nM
    99.74%
N-Desmethyltamoxifen
PKC
                   
PKCiota-IN-2  
PKCα, IC50: 71 nM
     
PKCε, IC50: 350 nM
       
PKCι, IC50: 2.8 nM
PKCδ Peptide Substrate        
PKCδ
           
PKC β pseudosubstrate    
PKC-β
                98.98%
PF-03622905  
PKCα, IC50: 5.6 nM
PKCβI, IC50: 14.5 nM
PKCβII, IC50: 13 nM
PKCγ, IC50: 37.7 nM
       
PKCθ, IC50: 74.1 nM
   
PS315            
PKCη, IC50: 30 μM
PKCζ, IC50: 10 μM
     
Aurora A/PKC-IN-1  
PKCα, IC50: 16.9 nM
                 
Evo312    
PKC-βI, IC50: 117.34 nM
               
[Ala113]MBP(104-118)
PKC, IC50: 28-62 μM
                   
PF-4950834            
PKCη, IC50: 756 nM
       
PKC β pseudosubstrate TFA    
PKCβ
               
[Ala107]MBP(104-118) TFA
PKC, IC50: 46-145 μM
                   
[Ala107]MBP(104-118)
PKC, IC50: 46-145 μM
                   
HA-100 hydrochloride
PKC, IC50: 12 μM
                   
[Ala113]MBP(104-118) TFA
PKC, IC50: 28-62 μM
                   
PKC-IN-4
PKC, IC50: 0.52 μM
                   
PF-04577806  
PKCα, IC50: 2.4 nM
PKCβI, IC50: 8.1 nM
PKCβII, IC50: 6.9 nM
PKCγ, IC50: 45.9 nM
PKCδ, IC50: 586 nM
PKCε, IC50: 522 nM
   
PKCθ, IC50: 29.5 nM
   
Bisindolylmaleimide VIII
Rat Brain PKC, IC50: 158 nM
PKCα, IC50: 53 nM
PKC-βI, IC50: 195 nM
PKC-βII, IC50: 163 nM
PKCγ, IC50: 213 nM
 
PKCε, IC50: 175 nM
         
CMPD101 hydrochloride  
PKCα, IC50: 8.1 μM
                 
Balanol  
Human PKCα, : 4-9 nM
PKC-βI, : 4-9 nM
PKC-βII, : 4-9 nM
Human PKCγ, : 4-9 nM
Human PKCδ, : 4-9 nM
Human PKCε, : 4-9 nM
human PKCη, : 150 nM
       
Dioleyl phosphatidylserine      
PKCγ
             
AS2521780  
PKCα, IC50: 160 nM
   
PKCδ, IC50: 160 nM
PKCε, IC50: 18 nM
   
PKCθ, IC50: 0.48 nM